GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmosa Biopharm Inc (ROCO:6875) » Definitions » Total Stockholders Equity

Pharmosa Biopharm (ROCO:6875) Total Stockholders Equity : NT$1,903.01 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Pharmosa Biopharm Total Stockholders Equity?

Pharmosa Biopharm's Total Stockholders Equity for the quarter that ended in Sep. 2024 was NT$1,903.01 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Pharmosa Biopharm's Book Value per Share for the quarter that ended in Sep. 2024 was NT$14.74. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Pharmosa Biopharm's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.06.

Pharmosa Biopharm Total Stockholders Equity Historical Data

The historical data trend for Pharmosa Biopharm's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmosa Biopharm Total Stockholders Equity Chart

Pharmosa Biopharm Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial -53.77 405.83 531.44 761.12 1,137.65

Pharmosa Biopharm Quarterly Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,229.04 1,137.65 2,050.42 1,991.91 1,903.01

Pharmosa Biopharm  (ROCO:6875) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Pharmosa Biopharm's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1903.006-0)/129.086
=14.74

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Pharmosa Biopharm's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(17.831 + 104.171) / 1903.006
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmosa Biopharm Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Pharmosa Biopharm's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmosa Biopharm Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmosa Biopharm Inc (ROCO:6875) » Definitions » Total Stockholders Equity
Comparable Companies
TPE:1760 ROCO:4167 TPE:6838 ROCO:4157 TPE:1734 TPE:4142 ROCO:4726 TPE:6949 ROCO:3176 ROCO:6808 VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
No.66, Sanchong Road, Nangang District, Taipei, TWN, 11502
Website
https://www.pharmosa.com.tw
Pharmosa Biopharm Inc is a world-class biotechnology company focusing on developing a new drug by exploiting proprietary formulation and manufacturing technology.

Pharmosa Biopharm Headlines

No Headlines